Live feed
Filing
SC 13G/A
SC 13G/A0001753926-24-000309·Biodexa Pharmaceuticals Plc
Schedule 13G ownership disclosure
BIODEXA PHARMACEUTICALS PLC
Security class unavailable · CUSIP: 59564R708
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 135,532
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-24-000309
- Form type
- SC 13G/A
- Filer
- Biodexa Pharmaceuticals Plc
- CIK
- CIK 1643918
- Filed
- Feb 14, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership